Article Processing Charges
Transparent, sustainable Open Access publishing for cancer research.
Invest in Accelerating Cancer Discoveries
The Journal of Neoplasms operates on a Gold Open Access model—your oncology research is immediately and freely accessible to clinicians, researchers, and patients worldwide. The Article Processing Charge funds rigorous peer review, professional production, and permanent archiving of your breakthrough findings.
No submission fees. No hidden costs. Payment only upon acceptance.
Research & Review Articles
- Original research articles
- Comprehensive review articles
- Systematic reviews & meta-analyses
- Clinical trial reports
- Full editorial processing
- Professional copyediting & typesetting
Short Communications
- Brief communications
- Technical notes
- Case reports
- Preliminary findings
- Rapid review processing
- Streamlined production workflow
Invited Content
- Editorial commentaries
- Letters to the editor
- Invited perspectives
- Conference highlights
- By invitation only
- Supports scientific dialogue
Expert Oncology Review
Coordination of reviews by oncologists, cancer biologists, clinical researchers, and biostatisticians ensures scientific validity and clinical relevance for the cancer research community.
Professional Production
High-quality copyediting, layout design, XML tagging, and conversion to PDF, HTML, and ePub formats for optimal readability across all devices and platforms.
Global Dissemination
Immediate Open Access ensures oncologists from major cancer centers to community practices can access your findings without subscription barriers, accelerating translation to patient care.
Permanent Archiving
Digital preservation through Crossref DOI registration and long-term archiving partnerships guarantees your contribution to cancer science remains accessible for future generations.
Geographic Waivers: Authors from Low-Income Countries (World Bank classification) are automatically eligible for 50-100% APC waivers. Middle-Income Country authors may apply for partial discounts based on demonstrated need or limited institutional funding for cancer research.
Membership Discounts
JN members receive 15-30% APC reductions depending on membership tier. Institutional Partners enjoy reduced rates for all affiliated authors. View membership options →
Cancer Research Funders
Major funders (NCI, NIH, CRUK, AACR) allow APCs as grant expenses. We provide compliance documentation and invoicing to satisfy all cancer research funder mandates for Open Access.
Publishing with JN represents an investment in maximum oncology research visibility. Unlike subscription journals that restrict access, JN ensures your work reaches every cancer researcher and clinician globally—from NCI-designated comprehensive cancer centers to oncology practices in developing nations. This unrestricted access translates to higher citation rates and accelerated translation to patient benefit.
The APC funds meticulous quality assurance including plagiarism screening with iThenticate, statistical review for clinical data, and image integrity analysis. We maintain the scientific record while protecting author reputation through rigorous pre-publication validation.
Invoices are issued upon manuscript acceptance. Payment is due within 15 days to prevent publication delays. We accept credit cards (Visa, MasterCard, Amex), bank transfers, and PayPal. Institutional purchase orders are accommodated for cancer center partners.
ManuscriptZone Portal
Full-featured submission system with real-time tracking, reviewer communication, and revision management. Submit via ManuscriptZone →
Simple Submission Form
Streamlined single-page upload for rapid manuscript submission without account creation. Use Simple Form →
Research groups publishing multiple articles benefit from volume pricing. Cancer research consortia and multi-center trial groups should contact our finance team to discuss institutional arrangements that support sustained Open Access publishing across collaborative oncology programs.
Ready to Publish Your Cancer Research?
Join the global oncology community with immediate Open Access publication.
We welcome your cancer research—submit today and maximize global impact.
